JAMP IRBESARTAN
JAMP IRBESARTAN
Approved
DIN Number
02545225
Drug Class
Human
Market Date
Feb 4, 2025
Company
HC
Jamp Pharma Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02545225
AIG Number0131700001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09CA04 IRBESARTAN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
IRBESARTANActive
Strength: 75 MG
Monograph: IRBESARTAN